Partnership to End Addiction encourages research on the medicinal value of marijuana and the use of any U.S. Food and Drug Administration (FDA)-approved medications derived from marijuana or containing cannabinoids.
The combination of several factors makes adolescence the critical period of vulnerability for beginning to use addictive substances and for developing the disease of addiction.
Addiction is a complex disease of the brain and body that involves compulsive use of one or more substances despite serious health and social consequences.
Tackling Youth Substance Abuse is a coalition of people and organizations with a mission to decrease youth and young adult substance use on Staten Island.
Medications prescribed by a physician are the most effective, potentially lifesaving, treatment for opioid addiction. Read more about our position on medication to treat addiction.
Partnership to End Addiction opposes the legalization of marijuana for recreational use because it will increase access to and use of the drug among adolescents.
Partnership to End Addiction supports the decriminalization of marijuana because it more appropriately addresses marijuana use as a public health problem, rather than a crime.
Partnership to End Addiction supports reducing barriers to effective substance use disorder treatment, including eliminating the DATA 2000 waiver required to prescribe buprenorphine.
We have compiled a comprehensive set of effective policies and practices that identifies specific actions for improving the prevention and treatment of risky substance use and addiction in the U.S.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
